Academic Journal
Q1The Annual Review of Pharmacology and Toxicology
About The Annual Review of Pharmacology and Toxicology
About The Annual Review of Pharmacology and Toxicology
The Annual Review of Pharmacology and Toxicology is a peer-reviewed scholarly journal published by Annual Reviews.
Key indicators: ISSN 03621642, 15454304.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
Publishing in The Annual Review of Pharmacology and Toxicology
When considering this journal, verify its current indexing status, editorial board, and recent publications to ensure it meets your needs for visibility and credibility.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of The Annual Review of Pharmacology and Toxicology?
03621642, 15454304.
Who publishes The Annual Review of Pharmacology and Toxicology?
Annual Reviews.
Where do I submit to The Annual Review of Pharmacology and Toxicology?
Via the official website.
Is The Annual Review of Pharmacology and Toxicology peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Journal Metrics
A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Pharmacological Individuality: The Twists and Turns of My Journey
Urs Albert Meyer
2026-10-07 · DOI: 10.1146/annurev-pharmtox-062425-044036Small Interfering RNA in Cardiovascular Disease: A New Frontier in Precision Medicine
Kaavya Paruchuri, Jaiden Busso, Pradeep Natarajan
2026-10-07 · DOI: 10.1146/annurev-pharmtox-062124-023947Placebo Pain Relief: Mechanisms and Therapeutic Opportunities
Chong Chen, Grégory Scherrer
2026-10-05 · DOI: 10.1146/annurev-pharmtox-060225-124705Introduction to the Theme “Context Is Everything: Defining the Factors That Contribute to Variability in Drug Response”
Susan G. Amara, Amrita Ahluwalia, Paul A. Insel
2026-10-05 · DOI: 10.1146/annurev-pharmtox-090826-125709Nanobodies as Versatile Next-Generation Biologics
Serge Muyldermans, Jan Steyaert
2026-10-02 · DOI: 10.1146/annurev-pharmtox-060425-094846Molecular Pharmacology of Dopamine Receptors: Structure, Function, and Therapeutic Implications
Youwen Zhuang, H. Eric Xu
2026-10-01 · DOI: 10.1146/annurev-pharmtox-060425-070659Emerging Roles of Mass Spectrometry–Based Proteomics in Drug Discovery
Ka Yang, Weiping Tang, Taosheng Chen, Junmin Peng et al.
2026-10-01 · DOI: 10.1146/annurev-pharmtox-060325-040513Novel Targets and Treatments for Neurodegenerative Diseases Revealed by Drosophila
Pablo Reina-Gonzalez, Aiesha Anchan, Jennifer Bekos, Abdulla Abu-Salah et al.
2026-09-25 · DOI: 10.1146/annurev-pharmtox-060325-064705Use of High-Resolution Mass Spectrometry in Therapeutic Drug Monitoring of Psychiatric Drugs
Espen Molden, Birgit M. Wollmann, Léon Reubsaet
2026-09-17 · DOI: 10.1146/annurev-pharmtox-060425-092716Precision Drug Discovery in the Era of Artificial Intelligence: A Critical Review
Mengya Liu, Jiacheng Xiong, Mingyue Zheng
2026-09-08 · DOI: 10.1146/annurev-pharmtox-060325-010428Protein Synthesis Dysregulation in Neurodegeneration: Mechanisms, Consequences, and Therapeutic Modulation
Karinder K. Brar, Adrian J. Butcher, Giovanna R. Mallucci
2026-09-08 · DOI: 10.1146/annurev-pharmtox-080125-105017New Natural Product Antibiotics: Strategies and Tools That Offer New Approaches to Overcome Traditional Roadblocks
Maya S.B. George, Marie I. Balea, Gerard D. Wright
2026-08-27 · DOI: 10.1146/annurev-pharmtox-060225-120509Making Drug Dosing Decisions Based on Therapeutic Monitoring
Leslie Z. Benet, Jasleen K. Sodhi
2026-08-14 · DOI: 10.1146/annurev-pharmtox-060325-032401Pharmacoexposomics: The Environmental Complement to Pharmacogenomics to Advance Precision Medicine
Paolo Reho, Vidhu V. Thaker, Arjun P. Athreya, Serge Cremers et al.
2026-08-13 · DOI: 10.1146/annurev-pharmtox-062624-113658Nonaddictive Analgesia: New Approaches That Target the Hodgkin-Huxley NaV/KV Dyad
Sidharth Tyagi, Mohammad-Reza Ghovanloo, Mark Estacion, Sulayman D. Dib-Hajj et al.
2026-08-13 · DOI: 10.1146/annurev-pharmtox-060325-034103Beyond Catalytic Inhibition: The Evolving Landscape of PARP Pharmacology
Michael C. Owens, Anthony K.L. Leung
2026-08-10 · DOI: 10.1146/annurev-pharmtox-060425-062841Vesicular Monoamine Transporters at the Crossroads of Structure and Function: Advances, Challenges, and Future Perspectives
Kai H. Lange, Michael P. Dalton, Suraj Kumar Mandal, Jonathan A. Coleman et al.
2026-08-07 · DOI: 10.1146/annurev-pharmtox-060225-123449The Pharmacology of CAR T Cell Therapy for Autoimmune Disease
Juliang Qin, Guangyu Zhang, Ning Zhao, Bing Du et al.
2026-08-03 · DOI: 10.1146/annurev-pharmtox-060225-095155Sex Differences in Secondary Prevention Pharmacotherapy for Acute Coronary Syndromes
Andrew J. Sullivan, Margaret Siu, Krishnaraj Rathod, Amrita Ahluwalia et al.
2026-07-21 · DOI: 10.1146/annurev-pharmtox-101325-092507Therapeutics for Alcohol-Associated Liver Disease
Marta Melis, Hamza Dahshi, Laura E Nagy
2026-07-20 · DOI: 10.1146/annurev-pharmtox-060225-121425Reviews
Community Reviews
Version History
October 11, 2026 at 2:36 am
October 9, 2026